Literature DB >> 15472296

Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium.

Vanessa Vankerckhoven1, Tim Van Autgaerden, Carl Vael, Christine Lammens, Sabine Chapelle, Rosaria Rossi, Daniela Jabes, Herman Goossens.   

Abstract

A multiplex PCR for the simultaneous detection of five virulence genes (asa1, gelE, cylA, esp, and hyl) in enterococci was developed. The presence of these genes was investigated in 153 clinical and 118 fecal Enterococcus faecium isolates from inpatients at an increased risk of developing infections (such as patients in intensive care units and hematology wards) from 13 hospitals in eight European countries. Of the 271 E. faecium isolates, 135 were vancomycin resistant E. faecium (VREF) isolates and 136 were vancomycin susceptible E. faecium (VSEF) isolates. Susceptibilities to ampicillin, gentamicin, streptomycin, vancomycin, teicoplanin, ramoplanin, quinupristin-dalfopristin, and linezolid were tested by the microdilution method. Overall, the prevalence of esp was significantly higher (P = 0.03) in clinical VREF isolates (92%) than in fecal VREF isolates (73%). In Italy, the prevalence of esp was significantly higher (P = 0.02) in VREF isolates (91%) than in VSEF isolates (68%), whereas in the United Kingdom, hyl was significantly more prevalent (P = 0.01) in VREF isolates (71%) than in VSEF isolates (29%). No significant differences were found for the other countries. Pulsed-field gel electrophoresis was used to check the clonality among the strains tested and showed the spread of two center-specific (esp-positive) VREF clones in Italy and one center-specific (hyl-positive) clone in the United Kingdom. These clones were resistant to ampicillin, gentamicin, and streptomycin. The multiplex PCR reported in this study is a convenient and rapid method for the simultaneous detection of the virulence genes asa1, gelE, cylA, esp, and hyl in enterococci. Molecular analysis showed the intrahospital spread of esp-positive VREF clones (in Italy) and hyl-positive VREF clones (in the United Kingdom); the role of hyl remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472296      PMCID: PMC522368          DOI: 10.1128/JCM.42.10.4473-4479.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

1.  Identification of a Tn1546-like (type 2) element in vancomycin-resistant Enterococcus faecium isolated from hospitalized patients in Japan.

Authors:  R Kariyama; H Kuman; A M Hammerum; F M Aarestrup; L B Jensen
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates.

Authors:  H A Elsner; I Sobottka; D Mack; M Claussen; R Laufs; R Wirth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-01       Impact factor: 3.267

3.  Multiplex PCR for detection of trait and virulence factors in enterohemorrhagic Escherichia coli serotypes.

Authors:  P Feng; S R Monday
Journal:  Mol Cell Probes       Date:  2000-12       Impact factor: 2.365

4.  Variant esp gene in vancomycin-sensitive Enterococcus faecium.

Authors:  L Baldassarri; L Bertuccini; M G Ammendolia; G Gherardi; R Creti
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

5.  Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

Authors:  V Shankar; A S Baghdayan; M M Huycke; G Lindahl; M S Gilmore
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection.

Authors:  N Shankar; C V Lockatell; A S Baghdayan; C Drachenberg; M S Gilmore; D E Johnson
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Multiplex PCRs for identification of Escherichia coli virulence genes.

Authors:  M A Pass; R Odedra; R M Batt
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

8.  Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals.

Authors:  R J Willems; W Homan; J Top; M van Santen-Verheuvel; D Tribe; X Manzioros; C Gaillard; C M Vandenbroucke-Grauls; E M Mascini; E van Kregten; J D van Embden; M J Bonten
Journal:  Lancet       Date:  2001-03-17       Impact factor: 79.321

9.  Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins.

Authors:  A M Berry; J C Paton
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

10.  Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates.

Authors:  T J Eaton; M J Gasson
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

View more
  137 in total

1.  Ecology of antibiotic resistance genes: characterization of enterococci from houseflies collected in food settings.

Authors:  Lilia Macovei; Ludek Zurek
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea.

Authors:  Won Sup Oh; Kwan Soo Ko; Jae-Hoon Song; Mi Young Lee; Sulhee Park; Kyong Ran Peck; Nam Yong Lee; Choon-Kwan Kim; Hyuck Lee; Shin-Woo Kim; Hyun-Ha Chang; Yeon-Sook Kim; Sook-In Jung; Jun Seong Son; Joon-Sup Yeom; Hyun Kyun Ki; Gun-Jo Woo
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy.

Authors:  Lucia Stampone; Maria Del Grosso; Delia Boccia; Annalisa Pantosti
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Food-borne enterococci and their resistance to oxidative stress.

Authors:  Barbora Vlková; Tomáš Szemes; Gabriel Minárik; Lubomíra Tóthová; Hana Drahovská; Ján Turňa; Peter Celec
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

5.  Postoperative Enterococcus faecalis endophthalmitis: virulence factors leading to poor visual outcome.

Authors:  Daisuke Todokoro; Takashi Suzuki; Shinichiro Kobayakawa; Haruyoshi Tomita; Yuichi Ohashi; Hideo Akiyama
Journal:  Jpn J Ophthalmol       Date:  2017-07-13       Impact factor: 2.447

6.  Influx of enterococci and associated antibiotic resistance and virulence genes from ready-to-eat food to the human digestive tract.

Authors:  Lilia Macovei; Ludek Zurek
Journal:  Appl Environ Microbiol       Date:  2007-08-31       Impact factor: 4.792

7.  Dogs are a reservoir of ampicillin-resistant Enterococcus faecium lineages associated with human infections.

Authors:  Peter Damborg; Janetta Top; Antoni P A Hendrickx; Susan Dawson; Rob J L Willems; Luca Guardabassi
Journal:  Appl Environ Microbiol       Date:  2009-02-20       Impact factor: 4.792

8.  Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China.

Authors:  M Kang; Y Xie; C He; Z X Chen; L Guo; Q Yang; J Y Liu; Y Du; Q S Ou; L L Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-24       Impact factor: 3.267

9.  Dispersion of multidrug-resistant Enterococcus faecium isolates belonging to major clonal complexes in different Portuguese settings.

Authors:  Ana R Freitas; Carla Novais; Patricia Ruiz-Garbajosa; Teresa M Coque; Luísa Peixe
Journal:  Appl Environ Microbiol       Date:  2009-05-15       Impact factor: 4.792

10.  Assessment of high-level gentamicin and glycopeptide-resistant Enterococcus faecalis and E. faecium clonal structure in a Portuguese hospital over a 3-year period.

Authors:  R Mato; F Almeida; R Pires; P Rodrigues; T Ferreira; I Santos-Sanches
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-31       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.